Thus, directing therapeutic interventions towards LSD1 may potentiate the innate immune system attributes of promptness, and affect inflammation within the context of tumor immunity, which vigilantly monitoring and eradicating the migration of tumor cells. The gene discussed is KDM1A; the disease is neoplasm.